Bolt Biotherapeutics (BOLT) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Bolt Biotherapeutics Revenue Highlights


Latest Revenue (Y)

$7.88M

Latest Revenue (Q)

$1.27M

Bolt Biotherapeutics Revenue by Period


Bolt Biotherapeutics Revenue by Year

DateRevenueChange
2023-12-31$7.88M37.48%
2022-12-31$5.73M354.68%
2021-12-31$1.26M445.45%
2020-12-31$231.00K7.44%
2019-12-31$215.00K100.00%
2018-12-31--

Bolt Biotherapeutics generated $7.88M in revenue during NA 2023, up 37.48% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Bolt Biotherapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$1.27M-75.82%
2024-03-31$5.27M152.47%
2023-12-31$2.09M-17.37%
2023-09-30$2.53M76.41%
2023-06-30$1.43M-21.52%
2023-03-31$1.83M29.41%
2022-12-31$1.41M-33.19%
2022-09-30$2.11M51.62%
2022-06-30$1.39M71.34%
2022-03-31$813.00K60.04%
2021-12-31$508.00K-32.45%
2021-09-30$752.00K100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30--100.00%
2020-06-30$67.00K-59.15%
2020-03-31$164.00K152.31%
2019-12-31$65.00K-46.28%
2019-09-30$121.00K734.48%
2019-06-30$14.50K-
2019-03-31$14.50K-

Bolt Biotherapeutics generated $1.27M in revenue during Q2 2024, up -75.82% compared to the previous quarter, and up 69.82% compared to the same period a year ago.

Bolt Biotherapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CTMXCytomX Therapeutics$101.21M$25.11M
SPROSpero Therapeutics$96.73M$10.20M
BOLTBolt Biotherapeutics$7.88M$1.27M
ASMBAssembly Biosciences$7.16M$5.79M
NXTCNextCure--
TILInstil Bio--
NLTXNeurogene--
ACHLAchilles Therapeutics--
NUVBNuvation Bio-$1.44M

BOLT Revenue FAQ


Bolt Biotherapeutics's yearly revenue for 2023 was $7.88M, representing an increase of 37.48% compared to 2022. The company's yearly revenue for 2022 was $5.73M, representing an increase of 354.68% compared to 2021. BOLT's yearly revenue for 2021 was $1.26M, representing an increase of 445.45% compared to 2020.

Bolt Biotherapeutics's quarterly revenue for Q2 2024 was $1.28M, a -75.82% decrease from the previous quarter (Q1 2024), and a -11.03% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $5.27M, a 152.47% increase from the previous quarter (Q4 2023), and a 188.83% increase year-over-year (Q1 2023). BOLT's quarterly revenue for Q4 2023 was $2.09M, a -17.37% decrease from the previous quarter (Q3 2023), and a 48.05% increase year-over-year (Q4 2022).

Bolt Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was 525.08%, and for the last 5 years (2019-2023) was 3563.26%.